Opis działalności
HAEMATO AG was founded in 1993 and is a stock exchange quoted pharmaceutical company. The company is listed on the Frankfurt Stock Exchange in the Entry Standard (Open Market) and is based in Schönefeld / Germany. HAEMATO AG is active within the pharmaceutical industry and is specialized in the growing markets of patent protected and patent free medications. The core focus lies in the therapeutic areas oncology, HIV/AIDS and other chronic diseases.
Zarząd & Rada nadzorcza
| CEO |
| Patrick Brenske |
| Zarząd |
| Attila Strauss |
| Rada nadzorcza |
| Andrea Grosse, Prof. Dr. Dr. Sabine Meck, Uwe Zimdars |
Dane firmy
| Nazwa: |
HAEMATO AG |
| Adres: |
Lilienthalstraße 5c,D-12529 Schönefeld |
| Telefon: |
+49-30-677-9867-600 |
| Fax: |
+49-30-677-9867-707 |
| E-mail: |
service@haemato.de
|
| Internet: |
www.haemato.de |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
24,20% |
| Data IPO: |
05.12.2005 |
Relacje inwestorskie
| Nazwa: |
- |
| Telefon: |
- |
| Fax: |
- |
| E-mail: |
ir@haemato.de
|
